Access Is Power: Opioid Use Disorder and Reproductive Health

Fact Sheet

Access Is Power: Opioid Use Disorder and Reproductive Health

Generic Fact Sheet image

As the incidence of opioid use disorder in pregnancy has increased, so too has the number of infants born with neonatal abstinence syndrome (NAS). Women with opioid use disorder are at increased risk for unplanned pregnancy. Given this increased risk, one primary prevention strategy for reducing the incidence of NAS and utilization of the foster system that states and communities should consider is to address the reproductive health needs of individuals with substance use disorder (SUD). For women not in recovery, many barriers including cost, fear of mistreatment, and lack of transportation, contribute to a high rate of unplanned pregnancy. Even for those in recovery, barriers remain. This brief highlights several state and local initiatives to increase knowledge about, and access to, reproductive health services for women with SUD.

July 2018

Related Resources

Fact Sheet
In 2022, Title X-supported clinics provided contraceptive care to 6,399 women in New Mexico. The number of women served from 2018-2022 declined by 62.8%.
Fact Sheet
In 2022, Title X-supported centers provided contraceptive care to 98,134 women in New Jersey, the first time it has approached such high levels since 2018.
Fact Sheet
In 2022, Title X-supported clinics provided contraceptive care to 28,832 women in Minnesota. The number of women served from 2018-2022 declined by 38.9%.
Fact Sheet
This fact sheet summarizes federal funding streams for teen and unplanned pregnancy prevention and provides information about grantees who received funding.